Clinical Trial Update: Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease Treatment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating colchicine to reduce symptoms and lower inflammation in calcium pyrophosphate deposition disease (CPPD). The study is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Calcium Pyrophosphate Deposition Disease

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: CPPD - Calcium Pyrophosphate Deposition Disease | Phase 2 | Status: NOT_YET_RECRUITING